CRISPR Gene Therapy of the Eye: Targeted Knockout of Vegfa in Mouse Retina by Lentiviral Delivery

Publikation: Bidrag til bog/antologi/rapport/proceedingBidrag til bog/antologiForskningpeer review

Genome editing and knockout by virus-based delivery of CRISPR/Cas9 may provide a new option to cure inherited and acquired ocular diseases. Here we describe development and application of lentivirus-based delivery vectors enabling knockout of the Vegfa gene. We show that Streptococcus pyogenes (Sp) Cas9 and single-guide RNAs (sgRNAs) delivered by such vectors selectively can ablate the vascular endothelial growth factor A (Vegfa) gene in mouse retina following a single administration. These findings may contribute to the development of a new therapeutic path in the treatment of ocular diseases including exudative age-related macular degeneration (AMD).

OriginalsprogEngelsk
TitelCRISPR Gene Editing
RedaktørerYonglun Luo
Antal sider22
ForlagHumana Press
Udgivelsesår2019
Sider307-328
ISBN (trykt)978-1-4939-9169-3
ISBN (Elektronisk)978-1-4939-9170-9
DOI
StatusUdgivet - 2019
SerietitelMethods in Molecular Biology
Vol/bind1961
ISSN1064-3745

Se relationer på Aarhus Universitet Citationsformater

ID: 168651950